-
The Evolution of Pharma Depends on Data Integration and Application
The potential applications for this vast quantity and variety of data are nearly endless.
PAP-Q4-18-NI-001 -
The Coming of Age of Amorphous Solid Dispersions
Numerous drugs formulated as amorphous solid dispersions have been successfully commercialized.
PAP-Q4-18-CL-004 -
From Proof of Concept to Commercialization
Brammer’s vision is to be the leading CDMO for viral vector supply to cell and gene therapy innovators.
PAP-Q4-18-CL-003 -
Knowledge and Experience Equal Successful Technology Transfer
Technology transfer should result in the transfer of product and process knowledge into a new phase of the life cycle.
PAP-Q4-18-CL-008 -
A Turnkey Solution: Sourcing Equipment and Empowering Operators
We offer a turnkey solution by sourcing equipment that meets production line requirements.
PAP-Q4-18-CL-007 -
Designing Effective Facilities to Meet the Growing Demand for Oligonucleotide Drugs
An oligo drug manufacturing facility incorporates aspects of small-molecule and biologic drug facilities.
PAP-Q4-18-CL-002 -
Regulatory Spotlight: FDA Delays Enforcement of Serialization Mandate
The FDA issued new guidances regarding enforcement of the DSCSA's track and trace mandate.
PAP-Q4-18-NI-011 -
Big Data in Drug Development and Discovery
Companies that apply the data will have a competitive advantage in drug discovery and development.
PAP-Q4-18-NI-006 -
Big Data in Drug Manufacturing
To achieve cohesive data integration in drug manufacturing, systems must be aligned.
PAP-Q4-18-NI-005 -
Big Data in Drug Packaging and Distribution
The emphasis on serialization is a tangible move toward making post-market data mining more robust.
PAP-Q4-18-NI-004 -
Preparing Clinical Trial Logistics for a No-Deal Brexit
Pharmaceutical companies should prepare for Brexit by mitigating their supply chain risks.
PAP-Q4-18-CL-006 -
Drug Repositioning: Facilitating Drug Repositioning with Artificial Intelligence
Computer-based approaches are essential to enable systematic drug repositioning efforts.
PAP-Q4-18-NI-009 -
The Value of Complementary Specialized Capabilities
Continued investment in innovations that address the needs of current and next-generation therapies is essential.
PAP-Q4-18-CL-001 -
Risk Minimization with an Integrated Global Network
Collaborating with an embedded organization with an integrated, global network can facilitate access to growing markets.
PAP-Q4-18-CL-005 -
Preparative Chromatography
Servier’s InnoPreP™ technology offering appeals to mid-size pharmas who need to quickly move their project into clinical studies .
PAP-Q4-18-NI-002 -
New Drug News: Regulatory Approval Brings siRNA into the Rare Disease Toolbox
siRNA joins the other nucleic acid–based drugs entering the marketplace for the treatment of rare diseases.
PAP-Q4-18-NI-010 -
Foreign Investment: Chinese Capital Backs U.S. Biotech
Given the amount of Chinese capital and the growing interest in the segment, the market feels unlimited.
PAP-Q4-18-NI-008 -
Q: What Innovative Technologies Had the Greatest Impact on your Company this Year? What Were the Impacts?
Industry leaders discuss recent technological innovations.
PAP-Q4-18-NI-007 -
Q: Looking Forward, What New Technologies/Paradigms Do You Anticipate Having the Greatest Impact Next Year (Digitalization and Industry 4.0, Serialization, etc.)?
Industry leaders discuss forthcoming technological innovations.
PAP-Q4-18-NI-003
-
Oral Solid Dose Manufacturing Efficiency is Driving New Attention to Plant Design
Witold Lehmann, PE, Senior Process Engineer for CRB USA explains the drivers behind strategic planning and efficient production.
-
The Importance of Flexibility: Competitive Solutions in an Era of Innovation
Nice Insight is in conversation with Uwe Harbauer, Senior Vice President, Pharma Business Unit, Bosch Packaging Technology, to discuss how equipment supplier/pharma company relationships have changed over time, including the growing importance of longer-term, more strategic interactions.
-
Supply Chain Management and the Importance of Security of Supply
Syed T. Husain, Chief Commercial Officer at Alcami explains the importance of strengthening the security of supply.
-
Knowledge and Experience Equal Successful Technology Transfer
Joe Szczesiul, Director of Technical Services at UPM Pharmaceuticals, outlines best practices for effective tech transfer.
-
Dry-Powder Inhalation Formulation: Balancing Performance and Manufacturability
Eunice Costa, Group Leader, Inhalation and Conrad Winters, Director Drug Product Development at Hovione explain composite particle technology.
-
Artificial Intelligence in Biopharmaceutical Manufacturing
Constantin Loghinov, Managing Director, Machine Intelligence for Life Sciences, MILS Group LLC explains how AI has the power to change the healthcare industry.
-
CVS Health Acquisition of Aetna to Close before Thanksgiving
The deal will move forward now that CVS has received approval from 23 out of 28 states.
-
NextCure Bags $40 Million from Eli Lilly
Lilly hopes to leverage NextCure’s FIND-IO technology for cancer immunotherapy development.
-
Statement from FDA Commissioner Scott Gottlieb, M.D., on Proposed New Steps to Protect Youth by Preventing Access to Flavored Tobacco Products
Gottlieb comments on tobacco prevention.
-
NIH $1.4M Grant Supports Study into Precision Bioelectronic Medicine
Study uses endoscopy technologies to place bioelectronic medicine devices closer to organs without surgery.
-
Making Real-Time Process Analytical Technology In Biomanufacturing A Reality
Clint Pepper, Ph.D., Director of MAST Technology at Capsugel, explains the Modular Automated Sampling Technology platform.
-
Managing the Complexities of Outbound Clinical Drug Distribution
Wes Wheeler, CEO and Ariette van Strien, Chief Commercial Officer at Marken explain the importance of clinical logistics organizations.
-
Energizing Client Portfolios with Patient-Friendly Dosage Forms
Don Barbieri, Technical Products Manager, EDD at SPI Pharma discusses how to reduce patient noncompliance with excipients.
-
Designing Effective Facilities to Meet the Growing Demand for Oligonucleotide Drugs
Bill Jarvis, Chief Chemical Engineer, and Brendan Nichols, Process Engineer, CRB USA, discuss the challenges of designing facilities to manufacture oligonucleotide drugs.
-
From Blobs to Hearts: Understanding the 3D Bioprinting Revolution
The sci-fi dream of regenerative medicine is coming to life via 3D bioprinters.
-
How is the Need to Provide Local Drug-Product Supply in Multiple Regions Around the World Impacting Pharmaceutical Manufacturing Facility and Equipment Design?
Experts from across the industry lend their thoughts to the Roundtable.
-
Eli Lilly, Dicerna to Collaborate on RNAi Drug Development
Eli Lilly invests $100 million in partnership focused on cardio-metabolic disease, neurodegeneration and pain drugs.
-
GSK Opens New Facility in Scotland
The plant will manufacture Ellipta products.
-
Regen BioPharma, Inc. Reports Additional New NR2F6 Small Molecule Inhibitors
Research supports work toward new treatments for cancer.
-
Infectious Diseases Experts Convene to Explore Lifesaving Antibiotic Research Methods
Specialists shape agenda for combating overuse and misuse of antimicrobials.
Nice Insight Awareness/Perception Scorecard
Research. Compare. Contact. Find the Ideal Partner.
Customer Awareness (CA) describes a buyer’s knowledge of your offering, while Customer Perception (CP) describes how a buyer rates your company based on that knowledge. Nice Insight’s CA/CP scorecard allows you to measure market awareness and perception of you and your industry peers based on acknowledged outsourcing drivers.
- Search by company type, region, market segment and services.
- Select up to 5 companies to compare.
- View CA & CP performance scores against industry benchmark ratings.
Latest
View All LatestCVS Health Acquisition of Aetna to Close before Thanksgiving
Nov 13, 2018 11:51:29 AM PAO-M11-18-NI-009Eli Lilly, Dicerna to Collaborate on RNAi Drug Development
Nov 5, 2018 12:45:40 PM PAO-M11-18-NI-006Third PCSK9 Inhibitor for Lowering Cholesterol Moves into Phase III Trials
Nov 5, 2018 12:41:51 PM PAO-M11-18-NI-005High-Valued Start-Up Announces Positive Results for Osteoarthritis Drug
Nov 5, 2018 12:33:48 PM PAO-M11-18-NI-003
TOPICS
View All TopicsPRESS RELEASES
View All-
Arena Pharmaceuticals and United Therapeutics Announce Global License Agreement for Ralinepag
Nov 16, 2018 5:00:00 AM -
Patients Launch New Study to Shed Light on EGFR-Positive Lung Cancers
Nov 16, 2018 5:00:00 AM -
NIH $1.4M Grant Supports Study into Precision Bioelectronic Medicine
Nov 16, 2018 5:00:00 AM
Nice Insight Industry Benchmark Reports 2017
Download Sample Report
